Appointment booking for Dr. Charles Pigott, MD is currently not available.Dr. Charles Pigott, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Charles Pigott, MD (he/him) is a Surgeon in Tupelo, MS with over 18 years of experience. What is your opinion of Dr. Charles Pigott, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Charles Pigott, MD has received over $15,084 which includes payments from the following companies:
$13,065.60 from Intuitive Surgical, Inc.
$475.84 from W. L. Gore & Associates, Inc.
$330.14 from Ethicon US, LLC
$183.30 from Covidien Sales LLC
$96.62 from Cumberland Pharmaceuticals, Inc.
$82.79 from Medtronic USA, Inc.
$74.02 from Merck Sharp & Dohme Corporation
$71.33 from Covidien LP
$65.03 from Baxter Healthcare
$63.56 from LifeCell Corporation
$55.13 from The Medicines Company
$46.75 from Mallinckrodt LLC
$40.37 from Allergan Inc.
$40.00 from PORTOLA PHARMACEUTICALS, INC.
$38.23 from TEI Biosciences Inc
$33.32 from KCI USA, Inc
$32.94 from Convatec Inc.
$30.90 from HALYARD HEALTH, INC.
$29.63 from Molnlycke Health Care US, LLC
$29.00 from LeMaitre Vascular, Inc.
Payments received by Dr. Charles Pigott, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!